Personalized Medicine – Diagnostics and Therapy

Project acronym: PerMed Diagnostics and Therapy
Project title: Personalized Medicine – Diagnostics and Therapy
Project registration number: TN01000013
State funding provider: Technology Agency of the Czech Republic
Programme: TN - Programme for the Support of Applied Research, Experimental Development and Innovation National Centres of Competence (2018 - 2028)
Start date: 2019-01-01
End date: 2022-12-31
Principal investigator: Hajdúch Marián M.D., Ph.D.

Center PerMedT is focused on applied research in diagnostics and therapy of rare and genetically determined diseases. The aim is to develop both personalized diagnostic methods as well as drug candidates/drugs which would help specific groups of patients. The approach is highly interdisciplinary – from chemistry to biology, from genetics to bioinformatics. The research is divided into target validation, medicinal chemistry, biological chemistry and preclinical development, biomarkers and DNA analyses. Results of the PerMed are commercialized both by licensing and/or spin-off incorporation.